Total Visits

Views
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. 72

Total Visits Per Month

March 2019April 2019May 2019June 2019July 2019August 2019September 2019
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. 0 2 8 8 3 5 11

File Visits

Views
12885_2018_Article_4442.pdf 56

Top country views

Views
United States 41
Egypt 6
United Kingdom 3
Germany 2
Pakistan 2
Canada 1
Russia 1

Top cities views

Views
Ashburn 10
Fairfield 9
Cambridge 7
Woodbridge 4
Houston 3
Islamabad 2
Mountain View 2
Ann Arbor 1
Wilmington 1